LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Revenue

In the year 2023, LAVA Therapeutics had annual revenue of $7.52M, a decrease of -63.54%. Revenue in the quarter ending December 31, 2023 was $392.22K, a -86.03% decrease year-over-year.

• Revenue (ttm): $7.52M
• Revenue Growth: -63.54%
• P/S Ratio: 9.37
• Revenue / Employee: $203,273
• Employees: 37
• Market Cap: 70.45M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.52M	-13.11M	-63.54%
Dec 31, 2022	20.63M	14.55M	239.31%
Dec 31, 2021	6.08M	1.51M	33.05%
Dec 31, 2020	4.57M	-	-
Dec 31, 2019	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.